Division of Pediatric Hospital Medicine, Department of Pediatrics, Lucile Packard Children's Hospital Stanford and School of Medicine, Stanford University, Palo Alto, California;
Division of Emergency Medicine, Boston Children's Hospital and Harvard Medical School, Harvard University, Boston, Massachusetts.
Hosp Pediatr. 2021 Jan;11(1):100-105. doi: 10.1542/hpeds.2020-002204. Epub 2020 Dec 14.
To describe the characteristics and outcomes of afebrile infants ≤60 days old with invasive bacterial infection (IBI).
We conducted a secondary analysis of a cross-sectional study of infants ≤60 days old with IBI presenting to the emergency departments (EDs) of 11 children's hospitals from 2011 to 2016. We classified infants as afebrile if there was absence of a temperature ≥38°C at home, at the referring clinic, or in the ED. Bacteremia and bacterial meningitis were defined as pathogenic bacterial growth from a blood and/or cerebrospinal fluid culture.
Of 440 infants with IBI, 78 (18%) were afebrile. Among afebrile infants, 62 (79%) had bacteremia without meningitis and 16 (20%) had bacterial meningitis (10 with concomitant bacteremia). Five infants (6%) died, all with bacteremia. The most common pathogens were (35%), (16%), and (16%). Sixty infants (77%) had an abnormal triage vital sign (temperature <36°C, heart rate ≥181 beats per minute, or respiratory rate ≥66 breaths per minute) or a physical examination abnormality (ill appearance, full or depressed fontanelle, increased work of breathing, or signs of focal infection). Forty-three infants (55%) had ≥1 of the following laboratory abnormalities: white blood cell count <5000 or >15 000 cells per μL, absolute band count >1500 cells per μl, or positive urinalysis. Presence of an abnormal vital sign, examination finding, or laboratory test result had a sensitivity of 91% (95% confidence interval 82%-96%) for IBI.
Most afebrile young infants with an IBI had vital sign, examination, or laboratory abnormalities. Future studies should evaluate the predictive ability of these criteria in afebrile infants undergoing evaluation for IBI.
描述无发热(体温<38℃)≤60 天的侵袭性细菌感染(IBI)婴儿的特征和结局。
我们对 2011 年至 2016 年期间 11 家儿童医院急诊科就诊的≤60 天 IBI 婴儿进行了一项横断面研究的二次分析。我们将无发热定义为家中、转诊诊所或急诊科无体温≥38℃的婴儿。菌血症和细菌性脑膜炎定义为血液和/或脑脊液培养中出现致病性细菌生长。
在 440 例 IBI 婴儿中,78 例(18%)为无发热。在无发热婴儿中,62 例(79%)为无脑膜炎菌血症,16 例(20%)为细菌性脑膜炎(10 例合并菌血症)。5 例(6%)婴儿死亡,均为菌血症。最常见的病原体为(35%)、(16%)和(16%)。60 例(77%)婴儿有异常分诊生命体征(体温<36℃、心率≥181 次/分钟或呼吸频率≥66 次/分钟)或体格检查异常(表现不佳、饱满或凹陷的囟门、呼吸功增加或局部感染迹象)。43 例(55%)婴儿有≥1 项以下实验室异常:白细胞计数<5000 或>15000 个/μL、绝对带计数>1500 个/μl 或尿液分析阳性。异常生命体征、检查发现或实验室检查结果的存在对 IBI 的敏感性为 91%(95%置信区间 82%-96%)。
大多数患有 IBI 的无发热年轻婴儿有生命体征、检查或实验室异常。未来的研究应评估这些标准在接受 IBI 评估的无发热婴儿中的预测能力。